SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy’s launches anti-allergy tablets in US

29 Mar 2011 Evaluate

Dr Reddy’s Laboratories has launched levocetirizine tablets,which are used for relieving allergies, in the American market. The product, which is a genericequivalent of UCB’s Xyzal tablets, is used to treat or prevent symptoms ofallergies. It is also used to help reduce itchy skin rash and hives.

The company has launched the tablet in 5 mg strength in theUS market. The tablets are available in 90 count bottles.According IMS HealthSales data, levocetirizine tablets posted sales of about $238 million in the USmarket for the 12-month period ended September 30, 2010.crackcrack

Dr. Reddys Lab Share Price

1232.25 -3.15 (-0.25%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×